These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 13063225)

  • 1. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
    KONIG FE
    Schweiz Med Wochenschr; 1953 Jan; 83(2):40-4. PubMed ID: 13056543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne].
    VUILLEUMIER P
    Rev Med Suisse Romande; 1953 Jan; 73(1):62-3. PubMed ID: 13075359
    [No Abstract]   [Full Text] [Related]  

  • 5. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
    PERCESEPE E
    Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pelentan therapy of thrombophlebitis].
    AFANAS'EVA LM
    Sov Med; 1953 Jul; 17(7):19-20. PubMed ID: 13089911
    [No Abstract]   [Full Text] [Related]  

  • 8. Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.
    BURKE GE; WRIGHT IS
    Circulation; 1951 Feb; 3(2):164-70. PubMed ID: 14812644
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with the treatment of thrombophlebitis with simultaneous application of pelentan and vitamin E].
    BRUCKNEROVA O
    Lek List; 1952 Nov; 7(22):549-52. PubMed ID: 13012120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Perivascular and lumbar sympathetic block alone and with anticoagulants in the treatment of phlebothrombosis or thrombophlebitis in obstetrics and gynecology].
    REVELLI E
    Minerva Cardioangiol; 1956 Feb; 4(2):106-8. PubMed ID: 13321615
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombotic diseases, especially treatment with tromexan].
    LINDAHL O
    Sven Lakartidn; 1956 Jan; 53(4):185-98. PubMed ID: 13311786
    [No Abstract]   [Full Text] [Related]  

  • 12. [PAPER CHROMATOGRAPHIC DEMONSTRATION OF THE ANTICOAGULANTS 3-(1-PHENYLPROPYL)-4-HYDROXYCOUMARIN (FALITHROM) AND THE ETHYL ESTER OF DIHYDROXYCOUMARINYLACETIC ACID (PELENTAN)].
    FROST E; SEIDLEIN HJ
    Pharm Prax; 1964; 204():28-33. PubMed ID: 14235737
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of ingestion of ethyl ester of bis-4-oxycoumarinyl acetic acid (tromexan) in suicide attempt].
    CATALANO V; NAVAZIO F
    Prog Med (Napoli); 1956 May; 12(9):274-5. PubMed ID: 13336168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 16. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions].
    PANCONESI E
    Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261
    [No Abstract]   [Full Text] [Related]  

  • 18. Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller.
    SCHELLENBERG W
    Praxis; 1953 Jul; 42(29):599-601. PubMed ID: 13088594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of venous thrombosis].
    ALAGILLE D
    Vie Med; 1953 Jun; 34(6):541-6. PubMed ID: 13102881
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc (Columbia); 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.